Heron Therapeutics is trading 5.2% up at $0.46, extending a multi-day rebound from last week’s lows.
- The move appears to be a continuation of recent speculative buying in the low-priced, high-volatility stock rather than a reaction to new information.
- There are no fresh company-specific headlines, earnings reports, or regulatory updates to account for the price action.
- No major analyst actions have been reported today, suggesting the rally is driven by technical momentum.